Conformational Diseases Group is interested in studying bacterial inclusion bodies as a model to treat amyloid aggregation based human disorders, such as Alzheimer or Parkinson’s diseases.
M. Antònia Busquets Viñas (Associate Professor) mabusquetsvinas(at)ub.edu
Alba Espargaró Colomé (Associate Professor)
Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer’s disease. Zaręba P.; Łątka K.; Mazur G.; Gryzło B.; Pasieka A.; Godyń J.; Panek D.; Skrzypczak-Wiercioch A.; Höfner G.C.; Latacz G.; Maj M.; Espargaró A.; Sabaté R.; Jóźwiak K.; Wanner K.T.; Sałat K.; Malawska B.; Kulig K.; Bajda M. 2023, European Journal of Medicinal Chemistry, 261, 115832. Doi: 10.1016/j.ejmech.2023.115832
Thioxanthenone-based derivatives as multitarget therapeutic leads for Alzheimer’s disease. Tonelli M.; Catto M.; Sabaté R.; Francesconi V.; Laurini E.; Pricl S.; Pisani L.; Miniero D.V.; Liuzzi G.M.; Gatta E.; Relini A.; Gavín R.; Del Rio J.A.; Sparatore F.; Carotti A. 2023 European Journal of Medicinal Chemistry, 250, 115169. Doi: 10.1016/j.ejmech.2023.115169
Coumarin derivatives against amyloid-beta 40 – 42 peptide and tau protein. Kowalczyk J., Skalicka-Wozniak K., Budzynska B., El Sayed N., Espargaró A., Sabate R. Current Issues in Pharmacy and Medical Sciences. 35, 2, 67, 2022
Design, Synthesis, and In Vitro, In Silico and In Cellulo Evaluation of New Pyrimidine and Pyridine Amide and Carbamate Derivatives as Multi-Functional Cholinesterase Inhibitors. Bortolami M., Pandolfi F., Tudino V., Messore A., Madia V.N., De Vita D., Di Santo R., Costi R., Romeo I., Alcaro S., Colone M., Stringaro A., Espargaró A., Sabatè R., Scipione L. Pharmaceuticals, 15, 6, 673, 2022
Characterisation of the enzymes involved in the diol synthase metabolic pathway in Pseudomonas aeruginosa. Shoja-Chaghervand S., Castells M., Rabanal F., Cajal Y., Manresa A., Estupiñán M., Busquets M. Process Biochemistry, 120, 301, 312, 2022
Dual Effect of Prussian Blue Nanoparticles on Aβ40 Aggregation: β-Sheet Fibril Reduction and Copper Dyshomeostasis Regulation. Kowalczyk J., Grapsi E., Espargaró A., Caballero A.B., Juárez-Jiménez J., Busquets M.A., Gamez P., Sabate R., Estelrich J. Biomacromolecules. 2021, 22, 2
Azobioisosteres of Curcumin with Pronounced Activity against Amyloid Aggregation, Intracellular Oxidative Stress, and Neuroinflammation. Hofmann J., Ginex T., Espargaró A., Scheiner M., Gunesch S., Aragó M., Stigloher C., Sabaté R., Luque F.J., Decker M. Chemistry – A European Journal. 2021, 27, 19
Air Curtains Equipped With Hydroalcoholic Aerosol Sprayers for Massive COVID-19 Disinfection. Raventós J., Sabate R. Frontiers in Public Health. 2021, 8, 582782
On the Binding of Congo Red to Amyloid Fibrils. Espargaró A., Llabrés S., Saupe S.J., Curutchet C., Luque F.J., Sabaté R. Angewandte Chemie – International Edition. 2020, 59(21)
1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer’s disease. Wichur T., Więckowska A., Więckowski K., Godyń J., Jończyk J., Valdivieso ÁD.R., Panek D., Pasieka A., Sabaté R., Knez D., Gobec S., Malawska B. European journal of medicinal chemistry. 2020, 187
Compuestos anti-amiloides fácilmente disponibles para prevenir la internalización celular de los coronavirus (PID2021-127863OB-I00). IP1: Raimon Sabaté Lagunas/IP2: Alba Espargaró Colomé. Convocatoria 2021 de ayudas a «Proyectos de Generación de Conocimiento». Modalidad Proyectos de «Investigación Orientada». Ministerio de Ciencia e Innovación (MICINN). From 2022 to 2025
“Nanocarriers for drug delivery through thermal release”. CTQ2017-88446-R. IP2: Sabaté, Raimon. Ministerio de Economía y Competitividad of Spain. 2018 –2020.